Good morning, folks, and how are you today? A spot of rain appears headed our way, but our spirits remain sunny. And why not? There is still time to enjoy the summer. But before we do so, there is work to be done. We trust you can relate. After all, the world has not stopped spinning, even if the pace has slowed. So before you dash off to cope with your next meeting or deadline, grab a cup of stimulation and peek at the tidbits below. And have a smashing day...
Teva Chairman Backs Management Amid Criticism (Bloomberg News)
Open Access To Studies Is Reaching A 'Tipping Point' (Pharma Times)
UK's MHRA To Inspect API Imports At Plants, Not Borders (InPharma Technologist)
Takeda Experimental Bowel Drug Was Effective In Studies (Bloomberg News)
FDA OKs Novo Nordisk Insulin Pen For Children (Drug Store News)
Dr. Reddy's Recalls Three Lots Of Ranitidine In The US (MoneyControl)
EDITOR'S NOTE: Please check this post for additional stories during the day